These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 27667581)

  • 1. Plant derived anti-cancerous secondary metabolites as multipronged inhibitor of COX, Topo, and aromatase: molecular modeling and dynamics simulation analyses.
    Singh S; Awasthi M; Pandey VP; Dwivedi UN
    J Biomol Struct Dyn; 2017 Nov; 35(14):3082-3097. PubMed ID: 27667581
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Natural Products as Anti-Cancerous Therapeutic Molecules Targeted towards Topoisomerases.
    Singh S; Pandey VP; Yadav K; Yadav A; Dwivedi UN
    Curr Protein Pept Sci; 2020; 21(11):1103-1142. PubMed ID: 32951576
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DNA topoisomerase-directed anticancerous alkaloids: ADMET-based screening, molecular docking, and dynamics simulation.
    Singh S; Das T; Awasthi M; Pandey VP; Pandey B; Dwivedi UN
    Biotechnol Appl Biochem; 2016; 63(1):125-37. PubMed ID: 25594242
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Natural Products as Anticancerous Therapeutic Molecules with Special Reference to Enzymatic Targets Topoisomerase, COX, LOX and Aromatase.
    Singh S; Awasthi M; Pandey VP; Dwivedi UN
    Curr Protein Pept Sci; 2018; 19(3):238-274. PubMed ID: 28059043
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lipoxygenase directed anti-inflammatory and anti-cancerous secondary metabolites: ADMET-based screening, molecular docking and dynamics simulation.
    Singh S; Awasthi M; Pandey VP; Dwivedi UN
    J Biomol Struct Dyn; 2017 Feb; 35(3):657-668. PubMed ID: 26942689
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular docking and 3D-QSAR-based virtual screening of flavonoids as potential aromatase inhibitors against estrogen-dependent breast cancer.
    Awasthi M; Singh S; Pandey VP; Dwivedi UN
    J Biomol Struct Dyn; 2015; 33(4):804-19. PubMed ID: 24702656
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of novel HER2 inhibitors against gastric cancer derived from flavonoid source of
    Babu TM; Rammohan A; Baki VB; Devi S; Gunasekar D; Rajendra W
    Drug Des Devel Ther; 2016; 10():3611-3632. PubMed ID: 27853354
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular Docking of Bioactive Compounds Against BRCA and COX Proteins.
    Prog Drug Res; 2016; 71():181-3. PubMed ID: 26939289
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phytochemical Profiling, In Vitro and In Silico Anti-Microbial and Anti-Cancer Activity Evaluations and Staph GyraseB and
    Mohammed HA; Khan RA; Abdel-Hafez AA; Abdel-Aziz M; Ahmed E; Enany S; Mahgoub S; Al-Rugaie O; Alsharidah M; Aly MSA; Mehany ABM; Hegazy MM
    Molecules; 2021 Jan; 26(3):. PubMed ID: 33499325
    [No Abstract]   [Full Text] [Related]  

  • 10. Molecular docking and dynamics simulation study of bioactive compounds from Ficus carica L. with important anticancer drug targets.
    Gurung AB; Ali MA; Lee J; Farah MA; Al-Anazi KM
    PLoS One; 2021; 16(7):e0254035. PubMed ID: 34260631
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Natural Product Inhibitors of Topoisomerases: Review and Docking Study.
    Scotti L; Bezerra Mendonca FJ; Ribeiro FF; Tavares JF; da Silva MS; Barbosa Filho JM; Scotti MT
    Curr Protein Pept Sci; 2018; 19(3):275-291. PubMed ID: 28079013
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular docking studies of curcumin natural derivatives with DNA topoisomerase I and II-DNA complexes.
    Kumar A; Bora U
    Interdiscip Sci; 2014 Dec; 6(4):285-91. PubMed ID: 25118649
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Computational approaches elucidate the allosteric mechanism of human aromatase inhibition: a novel possible route to Small-molecule regulation of CYP450s activities?
    Sgrignani J; Bon M; Colombo G; Magistrato A
    J Chem Inf Model; 2014 Oct; 54(10):2856-68. PubMed ID: 25178092
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Repurposing of approved drugs for targeting CDK4/6 and aromatase protein using molecular docking and molecular dynamics studies.
    Yousif FA; Alzain AA; Alraih AM; Ibraheem W
    PLoS One; 2023; 18(9):e0291256. PubMed ID: 37682937
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Curcumin induces high levels of topoisomerase I- and II-DNA complexes in K562 leukemia cells.
    López-Lázaro M; Willmore E; Jobson A; Gilroy KL; Curtis H; Padget K; Austin CA
    J Nat Prod; 2007 Dec; 70(12):1884-8. PubMed ID: 18076140
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular modeling of cationic porphyrin-anthraquinone hybrids as DNA topoisomerase IIβ inhibitors.
    Arba M; Ruslin ; Ihsan S; Tri Wahyudi S; Tjahjono DH
    Comput Biol Chem; 2017 Dec; 71():129-135. PubMed ID: 29153891
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Virtual Screening for Identification of Dual Inhibitors against CDK4/6 and Aromatase Enzyme.
    Adon T; Shanmugarajan D; Ather H; Ansari SMA; Hani U; Madhunapantula SV; Honnavalli YK
    Molecules; 2023 Mar; 28(6):. PubMed ID: 36985460
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The dietary flavonoids myricetin and fisetin act as dual inhibitors of DNA topoisomerases I and II in cells.
    López-Lázaro M; Willmore E; Austin CA
    Mutat Res; 2010 Feb; 696(1):41-7. PubMed ID: 20025993
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Discovery of novel aromatase inhibitors using a homogeneous time-resolved fluorescence assay.
    Ji JZ; Lao KJ; Hu J; Pang T; Jiang ZZ; Yuan HL; Miao JS; Chen X; Ning SS; Xiang H; Guo YM; Yan M; Zhang LY
    Acta Pharmacol Sin; 2014 Aug; 35(8):1082-92. PubMed ID: 25047514
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sulfonanilide Derivatives in Identifying Novel Aromatase Inhibitors by Applying Docking, Virtual Screening, and MD Simulations Studies.
    Rampogu S; Son M; Park C; Kim HH; Suh JK; Lee KW
    Biomed Res Int; 2017; 2017():2105610. PubMed ID: 29312992
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.